3rd Party Medical Device Industry News

Immorta Bio Reports | SenoVax™ Reduces Growth and Stops Metastasis of Aggressive Breast Cancer Using its First-In-Class Immune Stimulatory Therapy

SenoVax has previously been demonstrated to reduce lung cancer growth1, [...]

By |2024-10-29T14:38:01+00:00October 29, 2024|3rd Party Medical Device Industry News|Comments Off on Immorta Bio Reports | SenoVax™ Reduces Growth and Stops Metastasis of Aggressive Breast Cancer Using its First-In-Class Immune Stimulatory Therapy
Go to Top